« Return to News | CROs/Service Providers

Covance Q1 income above average

Friday, May 6, 2011 11:56 AM

U.S.-based drug development CRO Covance’s net revenues for the first-quarter of 2011 were $502 million, above the average analyst forecast, according to Pharma Times.

The CRO’s fourth-quarter and annual results for 2010 predicted a small increase in net revenues for the first quarter of 2011, mostly due to increased business under the company’s strategic alliance with sanofi-aventis.

Net revenues for the fourth quarter of 2010 were $491.5 million, so the $502 million for the latest quarter was in line with projections.

In the second quarter, Covance is looking for “a continued sequential increase” in net revenues and pro forma earnings per share of around $0.65.

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 30

Novartis-Walgreens pilot study blurring the line between retail pharmacy, investigative site

CISCRP to launch traveling science museum exhibit to demystify clinical trial participation

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

October

New growth and decline in Asia clinical trials
South Korea, Japan, China see big growth in 1572s, while India posts huge drop

Harnessing Big Data to transform clinical trials
From protocol to patient recruiting, data analytics can yield valuable insights

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

September

Sponsors look to collaborate on comparator drugs
Co-therapies, comparators are in 60% of studies, cost $25m per company a year

Early adopters implement risk-based monitoring pilot programs
Experiments aim to offer long-term solutions, despite short-term uncertainties

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs

More Jobs

 

Copyright © 1995-2013 CenterWatch.